In a group of health-related headlines, one says "Hope for new drug approach. As government-supported research in the US is being decimated by funding cuts, it was refreshing to attend iDR25 (the ...

Forbes contributors publish independent expert analyses and insights. Greg Licholai writes and teaches about innovation in healthcare. TxGNN is the first AI model specifically developed to identify ...

Drug repurposing identifies new uses for existing medicines, including approved drugs as well as investigational drugs that have demonstrated favourable pharmaceutical properties and human safety.

Drug repurposing holds immense promise when approached deliberately rather than as a fortunate accident, as Christopher Snyder and Sarrin Chethik argue in “You Can Teach an Old Drug New Tricks” (op-ed ...

Officials from nonprofit organizations, along with a former high-ranking US Food and Drug Administration (FDA) official, are considering mechanism to encouraging nonprofits to repurpose existing ...

Every Cure is using AI to seek new uses for the roughly 4,000 existing drugs, and cutting traditional preliminary research timelines from as much as 100 days to as little as 17 hours. Treatment for a ...

The US Food and Drug Administration (FDA) is asking for input on repurposing older drugs for new therapeutic uses to address unmet medical needs across a wide range of therapeutic areas. FDA said that ...

Universities and hospitals are repurposing existing drugs through late-stage trials with funded costs up to 90% lower than those in the pharmaceutical industry. This "hidden" research system, which ...

Announcing the RFI, FDA emphasized that “[d]rug repurposing can make better use of available scientific data to deliver effective treatment options for patients in need.” The initiative is not a ...